Kathmandu Univ Med J (KUMJ) 2013;11:206–9

Medical abortion versus manual vacuum aspiration in a hilly district hospital of eastern Nepal: a comparative study

Panta OP, Bhattarai D and Parajuli N

Abstract

Background: The Nepal government has approved medical abortion and manual vacuum aspiration for early first trimester pregnancy. Both procedures have been approved by World Health Organization for use in early first trimester.

Objectives: The study aims to compare efficacy and safety of medical abortion with surgical abortion in a district hospital of rural eastern Nepal.

Method: An observational study conducted in district hospital, Dhankuta, from July 2010 to January 2011. Clients for abortion services were counseled about methods of abortion and were allowed to make a decision on their own, and classified as medical abortion group (n = 48) (receiving 200 mg mifepristone followed by 800 mg misoprostol sublingually or vaginally on day two) and manual vacuum aspiration group (n = 36). The two groups were compared for rate of complete abortion and other complications and contraception use after the procedure.

Results: The rate of complete abortion was similar in both groups, 95.8% among medical abortion and 97.2% in manual vacuum aspiration. Moderate to severe expulsion bleeding was reported in 91.6% of cases after medical abortion but none required medical attention for hemorrhage. Condom was the most preferred contraceptive in medical abortion group and depo provera in manual vacuum aspiration group.

Conclusions: The medical method of abortion using mifepristone and misoprostol is equally safe and effective as manual vacuum aspiration in rural setting district hospitals of Nepal.

Comment: Manual vacuum aspiration and a combination of mifepristone and misoprostol are both good methods for a safe induced abortion. This elegant study shows that efficacy and safety of both methods are comparable and therefore it depends on the choice of the woman and the experience of the provider which one to choose. (Hans Vemer)